Ancillary Symposia 2016:
Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options
Browse by: | Sort by: |
Welcome and Introduction
Bernard Zinman
University of Toronto, Toronto, ON
Free
Slides + audio
Cardiovascular Risk Screening and Prevention: Who, When, How Often, What Medication?
Naveed Sattar, PhD, FRCP, FRCPath
University of Glasgow, Glasgow, United Kingdom
Free
Slides + audio
Cardiovascular Effects of Medications for Glycemic Control: Evidence from Large Outcomes Trials
Hertzel C Gerstein, MD,MSc,FRCPC
McMaster University, Hamilton, ON
Free
Slides + audio
SGLT-2 Inhibitors - Cardiovascular Impact and Safety Concerns
Silvio E Inzucchi, MD
Yale School of Medicine, New Haven, CT
Free
Slides + audio
Panel Discussion and Audience Questions
Bernard Zinman
University of Toronto, Toronto, ON
Free
Slides + audio